TABLE 4

Four-day multiple-dose pharmacokinetics of tamoxifen in fasted female beagle dogs

Dose (mg/kg)
P.O.
30
Dog I.D.4F98384F9848
Day1414
TAM
 Cmax (ng/mL)2286308316113505
 Tmax (h)4248
 Half-life14.11110.3566
 AUC0-24h (ng/mL*h)10913320941139167969
ENDX
 Cmax (ng/mL)37927770137
 Tmax (h)40.5248
 Half-life194N/Cb9.2
 AUC0-24h (ng/mL*h)321729359062189
 Metabolite ratio (%)b29.59.18.03.2
4HT
 Cmax (ng/mL)11201681937
 Tmax (h)411.58
 Half-life6.37.1N/CN/C
 AUC0-24h (ng/mL*h)49271228192.2436
 Metabolite ratio (%)45.23.81.70.6
NDMT
 Cmax (ng/mL)68317203971166
 Tmax (h)441224
 Half-life1622233.6
 AUC0-24h (ng/mL*h)680424062702824289
 Metabolite ratio (%)a62.375.061.735.7
  • Tmax, time to reach the maximum plasma concentration; I.D., identification; N/C, not calculate.

  • aMetabolite ratio calculated by dividing the AUC0-24h of the metabolite by the AUC0-24h or tamoxifen and multiplying by 100.

  • bData did not allow for calculation.